drugset / Trial / NCT02326051
Timing of Initiation of LMWH Administration in Pregnant Women With APS
RandomizedParallel-groupSingle-blindPrevention
Summary
Evaluation of the effect of altering the timing of initiation of low molecular weight heparin (LMWH) administration on the pregnancy outcomes in women with antiphospholipid syndrome (APS)
Timeline
- Start
- 2014-12
- Primary completion
- 2017-02
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |